InnoCan Pharma Corporation
INNO
Pozycja w akcjach
#33902
InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to... InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to innovating drug delivery systems that integrate cannabidiol (CBD) with other pharmaceutical compounds. Its operations and development efforts span across the United States, Poland, France, and various international markets. The company actively pursues research and development into treatments for conditions such as COVID-19, leveraging CBD delivered via exosomes and liposomes. InnoCan's product line features a range of CBD-infused topical items, including eye serum, face oil, face cream, facial serum, sleeping mask, recovery lotion, and the Relief & Go spray. Beyond R&D, the corporation is also involved in the marketing and distribution of its proprietary CBD-enhanced pharmaceutical and cosmetic offerings. Established in 2018, InnoCan Pharma Corporation maintains its principal office in Calgary, Canada.
Cena akcji
$1.39
Kapitalizacja rynkowa
$6.27M
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
-88.85%
Kraj
CA
Handel InnoCan Pharma Corporation (INNO)
Kategoria
Healthcare
EPS dla InnoCan Pharma Corporation (INNO)
EPS na dzień 2026 TTM: 0
Według najnowszych raportów finansowych i ceny akcji firmy InnoCan Pharma Corporation, obecny EPS (TTM) wynosi 0. Na koniec roku 2026 firma miała EPS w wysokości 0, równa się do EPS z roku 2026, który wynosił 0.
Historia EPS dla InnoCan Pharma Corporation od 2026 do 2026
EPS na koniec każdego roku
| Rok | EPS | Zmień |
|---|---|---|
| Za mało danych dla podanych dat. | ||
EPS dla podobnych firm lub konkurentów
| Firma | EPS | Różnica w EPS | Kraj |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | - |
IN
|
